Cargando…
Structural basis of omalizumab therapy and omalizumab-mediated IgE exchange
Omalizumab is a widely used therapeutic anti-IgE antibody. Here we report the crystal structure of the omalizumab–Fab in complex with an IgE-Fc fragment. This structure reveals the mechanism of omalizumab-mediated inhibition of IgE interactions with both high- and low-affinity IgE receptors, and exp...
Autores principales: | Pennington, Luke F., Tarchevskaya, Svetlana, Brigger, Daniel, Sathiyamoorthy, Karthik, Graham, Michelle T., Nadeau, Kari Christine, Eggel, Alexander, Jardetzky, Theodore S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873975/ https://www.ncbi.nlm.nih.gov/pubmed/27194387 http://dx.doi.org/10.1038/ncomms11610 |
Ejemplares similares
-
The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab
por: Gasser, Pascal, et al.
Publicado: (2020) -
Efficacy of Omalizumab Therapy in an Asthmatic with Low IgE
por: R, Divya, et al.
Publicado: (2020) -
Omalizumab and IgE in the Control of Severe Allergic Asthma
por: Gon, Yasuhiro, et al.
Publicado: (2022) -
Inhibition of IgE and IgE/anti-IgE mediated responses in mast cells by Omalizumab
por: Kulka, M, et al.
Publicado: (2010) -
Omalizumab in the management of patients with allergic (IgE-mediated) asthma
por: Sandström, Thomas
Publicado: (2009)